Company news
Protara Therapeutics, Inc. news in 2022
Protara Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Protara Therapeutics Announces Trials in Progress Poster Presentation for the ADVANCED-1 Trial in NMIBC at the 23rd Annual Meeting of the Society of Urologic Oncology
November 30, 2022
Protara Therapeutics Announces Third Quarter 2022 Financial Results and Business Overview
November 2, 2022
Protara Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 5, 2022
Protara Therapeutics Announces Second Quarter 2022 Financial Results and Business Overview
August 8, 2022
Protara Therapeutics Announces Departure of Chief Financial Officer
June 20, 2022
Protara Therapeutics Announces Trials in Progress Poster Presentation for the ADVANCED-1 Trial in NMIBC at the 2022 American Society of Clinical Oncology Annual Meeting
May 25, 2022
Protara Therapeutics to Present at the H.C. Wainwright Global Investment Conference
May 16, 2022
Protara Therapeutics Presents Results from Retrospective Analysis of Randomized and Open-Label Studies Evaluating the Safety and Efficacy of OK-432 in Patients with Lymphatic Malformations
May 11, 2022
Protara Therapeutics Announces First Quarter 2022 Financial Results and Business Overview
May 4, 2022
Protara Therapeutics Doses First Patient in ADVANCED-1 Phase 1 Study of TARA-002 in Non-Muscle Invasive Bladder Cancer
March 23, 2022
Protara Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Business Overview
March 8, 2022
Protara Therapeutics to Participate in the Guggenheim Healthcare Talks 2022 Oncology Conference
January 31, 2022
Protara Therapeutics Announces Appointment of Jathin Bandari, M.D. as Chief Medical Officer
January 9, 2022
Protara Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference
January 3, 2022